K-numberK252404
Device nameComprehensive Reverse Shoulder - HA Glenosphere Baseplates
ApplicantBiomet Orthopedics
Product codePHX
Device classClass II
Decision dateApr 15, 2026
DecisionSubstantially Equivalent
Regulation888.3660
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Comprehensive Reverse Shoulder - HA Glenosphere Baseplates is a shoulder joint replacement system designed for patients with severely deficient rotator cuff and severe arthropathy or failed prior shoulder replacement. It is indicated for primary, fracture, or revision reverse total shoulder replacement to relieve pain and disability in patients with grossly deficient rotator cuffs who have adequate deltoid muscle function.

Technological characteristics

The device features a reverse configuration with humeral trays, bearings, glenospheres, baseplates, and various screws. The key change from the predicate is the application of a dual Hydroxyapatite (HA) coating over a Ti6Al4V (titanium) substrate on the glenosphere baseplate components, intended for cementless applications with screw fixation. The baseplate substrate material and underlying PPS coating remain identical to the predicate device.

Test standards cited

Testing performed included biocompatibility assessment, shelf-life study, and characterization analyses using worst-case thickness and NIST Standard Reference Material (SRM) 2910b. Analyses encompassed elemental analysis, phase analysis, Ca/P ratio analysis, FTIR infrared analysis, dissolution rate testing, microstructural evaluation, static tensile testing, and shear fatigue testing.

Substantial equivalence argument

Substantial equivalence is established based on identical intended use and indications for use to the primary predicate (K193373), similar materials (identical substrate and underlying PPS coating; similar HA coating), identical design features and sterilization methods, and non-clinical testing demonstrating that the proposed dual HA/PPS coating of the glenosphere baseplate components meets all applicable acceptance criteria and establishes substantial equivalence.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →